Yuki Fukui

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Prognostic factors of pressure injury: a scoping review.

Prognostic factors of pressure injury: a scoping review.

Journal: Journal of tissue viability

Published: June 24, 2025

Impact of Fli1 deletion on B cell populations: A focus on age-associated B cells and transcriptional dynamics.

Impact of Fli1 deletion on B cell populations: A focus on age-associated B cells and transcriptional dynamics.

Journal: Journal of dermatological science

Published: July 18, 2024

Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.

Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.

Journal: Arthritis research & therapy

Published: June 20, 2021

The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts.

The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts.

Journal: The Journal of investigative dermatology

Published: May 16, 2021

Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis.

Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis.

Journal: International journal of rheumatic diseases

Published: December 02, 2020

Serum levels of tissue factor pathway inhibitor: Potential association with Raynaud's phenomenon and telangiectasia in patients with systemic sclerosis.

Serum levels of tissue factor pathway inhibitor: Potential association with Raynaud's phenomenon and telangiectasia in patients with systemic sclerosis.

Journal: The Journal of dermatology

Published: November 10, 2020

A potential contribution of decreased serum galectin-10 levels to systemic inflammation and pulmonary vascular involvement in systemic sclerosis.

A potential contribution of decreased serum galectin-10 levels to systemic inflammation and pulmonary vascular involvement in systemic sclerosis.

Journal: Experimental dermatology

Published: October 11, 2020

Serum vasohibin-1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis.

Serum vasohibin-1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis.

Journal: Experimental dermatology

Published: September 03, 2020

Association of serum CXCL12 levels with arthropathy in patients with systemic sclerosis.

Association of serum CXCL12 levels with arthropathy in patients with systemic sclerosis.

Journal: International journal of rheumatic diseases

Published: September 02, 2020

Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis.

Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis.

Journal: Experimental dermatology

Published: July 08, 2020

Decreased serum cathepsin S levels in patients with systemic sclerosis-associated interstitial lung disease.

Decreased serum cathepsin S levels in patients with systemic sclerosis-associated interstitial lung disease.

Journal: The Journal of dermatology

Published: March 02, 2020

Serum delta-like 4 levels: A possible association with interstitial lung disease in systemic sclerosis.

Serum delta-like 4 levels: A possible association with interstitial lung disease in systemic sclerosis.

Journal: The Journal of dermatology

Published: January 28, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026